These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24900790)

  • 1. Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.
    Thireau J; Marteaux J; Delagrange P; Lefoulon F; Dufourny L; Guillaumet G; Suzenet F
    ACS Med Chem Lett; 2014 Feb; 5(2):158-61. PubMed ID: 24900790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
    de la Fuente Revenga M; Herrera-Arozamena C; Fernández-Sáez N; Barco G; García-Orue I; Sugden D; Rivara S; Rodríguez-Franco MI
    Eur J Med Chem; 2015 Oct; 103():370-3. PubMed ID: 26367450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors].
    Schuster C
    J Soc Biol; 2007; 201(1):85-96. PubMed ID: 17762828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function.
    Oishi A; Cecon E; Jockers R
    Int Rev Cell Mol Biol; 2018; 338():59-77. PubMed ID: 29699692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
    Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
    J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
    Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
    J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling of MT1 and MT2 receptors.
    Farce A; Chugunov AO; Logé C; Sabaouni A; Yous S; Dilly S; Renault N; Vergoten G; Efremov RG; Lesieur D; Chavatte P
    Eur J Med Chem; 2008 Sep; 43(9):1926-44. PubMed ID: 18255198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XFEL structures of the human MT
    Johansson LC; Stauch B; McCorvy JD; Han GW; Patel N; Huang XP; Batyuk A; Gati C; Slocum ST; Li C; Grandner JM; Hao S; Olsen RHJ; Tribo AR; Zaare S; Zhu L; Zatsepin NA; Weierstall U; Yous S; Stevens RC; Liu W; Roth BL; Katritch V; Cherezov V
    Nature; 2019 May; 569(7755):289-292. PubMed ID: 31019305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
    Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptive responses in melatonin MT
    Posa L; Lopez-Canul M; Rullo L; De Gregorio D; Dominguez-Lopez S; Kaba Aboud M; Caputi FF; Candeletti S; Romualdi P; Gobbi G
    J Pineal Res; 2020 Oct; 69(3):e12671. PubMed ID: 32430930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening assay for new ligands at human melatonin receptors.
    Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the MT
    Liu J; Clough SJ; Dubocovich ML
    Genes Brain Behav; 2017 Jun; 16(5):546-553. PubMed ID: 28160436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular and chemical perspective in defining melatonin receptor subtype selectivity.
    Chan KH; Wong YH
    Int J Mol Sci; 2013 Sep; 14(9):18385-406. PubMed ID: 24018885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.
    Comai S; Gobbi G
    J Psychiatry Neurosci; 2014 Jan; 39(1):6-21. PubMed ID: 23971978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
    Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
    Jockers R; Maurice P; Boutin JA; Delagrange P
    Br J Pharmacol; 2008 Jul; 154(6):1182-95. PubMed ID: 18493248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep.
    Gobbi G; Comai S
    J Pineal Res; 2019 Apr; 66(3):e12544. PubMed ID: 30586215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.